Current Drug Targets - Cardiovascular & Hematological Disorders

Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
pp. 355-375(21)
Authors: Manolis, Antonis S.; Tzeis, Stylianos; Triantafyllou, Kostas; Michaelidis, John; Pyrros, Ioannis; Sakellaris, Nikolaos; Kranidis, Athanasios; Melita, Helen

Role of PPAR-γ Agonist Thiazolidinediones in Treatment of Pre-Diabetic and Diabetic Individuals: A Cardiovascular Perspective
pp. 377-386(10)
Authors: Dumasia, Rupal; Eagle, Kim A.; Kline-Rogers, Eva; May, Niquole; Cho, Leslie; Mukherjee, Debabrata

The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation
pp. 387-403(17)
Authors: Dilaveris, Polychronis; Giannopoulos, Georgios; Synetos, Andreas; Stefanadis, Christodoulos

Will this be the End of the Anticoagulation Clinic for Patients with Atrial Fibrillation?
pp. 405-408(4)
Author: Mitchell, Andrew R.J.

Drug Therapy in Brugada Syndrome
pp. 409-417(9)
Authors: Marquez, Manlio F.; Salica, Gabriel; Hermosillo, Antonio G.; Pastelin, Gustavo; Cardenas, Manuel

An Old Drug with a New Purpose: Cardiovascular Actions of Acetaminophen (Paracetamol)
pp. 419-429(11)
Authors: Spiler, Norell M.; Rork, Tyler H.; Merrill, Gary F.